FDA Issues Class II Recall for Over 25,000 Bottles of Blood Pressure Medication Chlorthalidone

The U.S. Food and Drug Administration (FDA) has issued a Class II recall for over 25,000 bottles of Chlorthalidone Tablets USP, 25 mg, distributed by Rising Pharma Holdings. The recall is due to the medication failing dissolution and potency tests, meaning patients may receive under-dosed medication. The affected tablets are light yellow, round, and carry the imprint '103'. Patients are advised to check their medication but not to stop taking it abruptly due to rebound hypertension risks. The recall covers specific lot numbers expiring in April 2027.